ETF Exchange > THNR ETF
THNR - ETF Fact Sheet
Amplify Weight Loss Drug & Treatment ETF - USD
Fund Identification
Ticker
THNR
ISIN
US0321085328
Main Metrics
Price
$26.93Expense Ratio
0.59%AuM
$5.39MTracking Difference
1.51%Ratings
Trackinsight rating
N/AOfficial Investment Strategy
The Amplify Weight Loss Drug & Treatment ETF seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index (the “Index”).
THNR's historical prices, performance, and flows
1m returns
6.17%
1m flows
$0M
* Net total returns
All data as of 2 September 2026
The ETF Exchange is brought to you by
With data and analysis by
See all THNR data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
THNR's characteristics
Manager
Manager statistics
48 funds, $21.25Bn in AUM
Benchmark
VettaFi Weight Loss Drug & Treatment Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
THNR's exposure
The THNR ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. We're working to retrieve all detailed holdings information.